YieldMax Innovation Option Income Strategy ETF (NYSEARCA:OARK – Get Free Report)’s stock price rose 0.1% during trading on Thursday . The stock traded as high as $31.69 and last traded at $31.66. Approximately 9,345 shares traded hands during mid-day trading, a decline of 61% from the average daily volume of 23,893 shares. The stock had previously closed at $31.63.
YieldMax Innovation Option Income Strategy ETF Price Performance
The firm’s fifty day simple moving average is $31.85 and its 200 day simple moving average is $34.77.
Institutional Investors Weigh In On YieldMax Innovation Option Income Strategy ETF
A hedge fund recently bought a new stake in YieldMax Innovation Option Income Strategy ETF stock. FNY Investment Advisers LLC purchased a new stake in YieldMax Innovation Option Income Strategy ETF (NYSEARCA:OARK – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,260 shares of the company’s stock, valued at approximately $45,000. FNY Investment Advisers LLC owned about 0.07% of YieldMax Innovation Option Income Strategy ETF as of its most recent filing with the Securities and Exchange Commission (SEC).
About YieldMax Innovation Option Income Strategy ETF
The YieldMax ARKK Option Income Strategy ETF (OARK) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund seeks to provide current income and capped gains on the ARK Innovation ETF (ARKK) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. OARK was launched on Nov 22, 2022 and is managed by YieldMax.
Recommended Stories
- Five stocks we like better than YieldMax Innovation Option Income Strategy ETF
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for YieldMax Innovation Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YieldMax Innovation Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.
